Market Overview:
The global peptide synthesizer market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for peptides in various applications such as school laboratories, biopharmaceutical companies, and synthesis services companies. North America is expected to dominate the global peptide synthesizer market during the forecast period owing to the presence of major players in this region and rising R&D expenditure on peptides. Asia Pacific is projected to be the fastest-growing region during the forecast period owing to growing demand for peptides from emerging countries such as China and India.
Product Definition:
A peptide synthesizer is an instrument used to create peptides through chemical synthesis. Peptides are important molecules that play a variety of roles in the body, including as hormones, enzymes, and receptors. The ability to synthesize peptides in a laboratory allows for the study of their structure and function, as well as the development of new therapeutics.
Mcg-mg:
The Mcg-mg is a peptide growth factor that stimulates the body's own protein synthesis machinery to make more of its own proteins. It also aids in increasing lean muscle mass, healing damaged cells and tissue, and reducing cataractous build up in the aging brain. The peptide growth factors are extracted from various sources including bovine milk, porcine intestinal mucosa extracts or transgenic mouse liver extracts.
Mg-g:
Magnesium-gluconate is a salt that consists of magnesium ion and gluconic acid anion. It has been used as a stabilizer in the synthesis of peptide molecules. The product is commercially available in two forms, namely, solid and liquid.
Application Insights:
The school laboratory segment accounted for the largest revenue share in 2016 and is anticipated to maintain its dominance over the forecast period. The growth of this application can be attributed to increasing usage of peptide therapeutics in schools across the globe. Moreover, introduction of new products by various players in order to cater to student¢â‚¬â„¢s needs will drive demand further.
Biopharmaceutical company was one of the fastest-growing segments with a CAGR around 11% from 2017 to 2030 owing to growing R&D activities pertaining peptide drugs. Companies are investing heavily on research & development activities due largely increase their focus on chronic diseases such as cancer, diabetes, and cardiovascular disorders which affect more than 7 billion people globally (USD Million) making it one of the leading causesof death worldwide (Growth Factors 2018). This has led pharmaceutical companies including Merck KGaA; Novo Nordisk A/S; Pfizer Inc.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of peptide developers and suppliers coupled with high healthcare spending is expected to drive the regional market over the forecast period. Asia Pacific is expected to be one of the fastest-growing regions during the same period owing to increasing awareness about peptide therapeutics, rising investment by multinational companies for drug discovery, and growing demand from end-use industries such as research laboratories & education. Moreover, an increase in government initiatives pertaining towards development of biopharmaceutical industry are anticipated to fuel growth over this region. For instance, ‘India’s Peptide Synthesizer’ initiative was launched by Department Of Biotechnology (DBT) India with an aim towards accelerating innovation through generation and utilization of new knowledge in life science & technology areas that include chemical biology & medicinal chemistry; vaccine design; drug discovery; bioinformatics etc.
Growth Factors:
- Increasing demand for peptides in the pharmaceutical and biotechnology industries as therapeutics and research tools
- Growing popularity of peptide-based drugs over traditional small molecule drugs
- Rising number of collaborations between pharmaceutical companies and peptide synthesis service providers to develop novel therapeutics
- Proliferation of personalized medicine approaches that require customized peptides for individual patients
- Technological advancements in peptide synthesis platforms that are making it easier and more affordable to synthesize complex peptides
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptide Synthesizer Market Research Report
By Type
Mcg-mg, Mg-g, G-kg, Abovekg
By Application
School laboratory, Biopharmaceutical Company, Synthesis Services Company
By Companies
AAPPTec, PTI, PSI, CEM, Biotage, Shimadzu, Activotec, CS Bio, Intavis AG, Hainan JBPharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Peptide Synthesizer Market Report Segments:
The global Peptide Synthesizer market is segmented on the basis of:
Types
Mcg-mg, Mg-g, G-kg, Abovekg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
School laboratory, Biopharmaceutical Company, Synthesis Services Company
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AAPPTec
- PTI
- PSI
- CEM
- Biotage
- Shimadzu
- Activotec
- CS Bio
- Intavis AG
- Hainan JBPharm
Highlights of The Peptide Synthesizer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mcg-mg
- Mg-g
- G-kg
- Abovekg
- By Application:
- School laboratory
- Biopharmaceutical Company
- Synthesis Services Company
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptide Synthesizer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A peptide synthesizer is a machine that can create peptides, which are short chains of amino acids. Peptides are important because they have many properties that make them useful in research and medicine.
Some of the major players in the peptide synthesizer market are AAPPTec, PTI, PSI, CEM, Biotage, Shimadzu, Activotec, CS Bio, Intavis AG, Hainan JBPharm.
The peptide synthesizer market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Peptide Synthesizer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Peptide Synthesizer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Peptide Synthesizer Market - Supply Chain
4.5. Global Peptide Synthesizer Market Forecast
4.5.1. Peptide Synthesizer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Peptide Synthesizer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Peptide Synthesizer Market Absolute $ Opportunity
5. Global Peptide Synthesizer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Peptide Synthesizer Market Size and Volume Forecast by Type
5.3.1. Mcg-mg
5.3.2. Mg-g
5.3.3. G-kg
5.3.4. Abovekg
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Peptide Synthesizer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Peptide Synthesizer Market Size and Volume Forecast by Application
6.3.1. School laboratory
6.3.2. Biopharmaceutical Company
6.3.3. Synthesis Services Company
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Peptide Synthesizer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Peptide Synthesizer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Peptide Synthesizer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Peptide Synthesizer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Peptide Synthesizer Demand Share Forecast, 2019-2026
9. North America Peptide Synthesizer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Peptide Synthesizer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Peptide Synthesizer Market Size and Volume Forecast by Application
9.4.1. School laboratory
9.4.2. Biopharmaceutical Company
9.4.3. Synthesis Services Company
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Peptide Synthesizer Market Size and Volume Forecast by Type
9.7.1. Mcg-mg
9.7.2. Mg-g
9.7.3. G-kg
9.7.4. Abovekg
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Peptide Synthesizer Demand Share Forecast, 2019-2026
10. Latin America Peptide Synthesizer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Peptide Synthesizer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Peptide Synthesizer Market Size and Volume Forecast by Application
10.4.1. School laboratory
10.4.2. Biopharmaceutical Company
10.4.3. Synthesis Services Company
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Peptide Synthesizer Market Size and Volume Forecast by Type
10.7.1. Mcg-mg
10.7.2. Mg-g
10.7.3. G-kg
10.7.4. Abovekg
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Peptide Synthesizer Demand Share Forecast, 2019-2026
11. Europe Peptide Synthesizer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Peptide Synthesizer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Peptide Synthesizer Market Size and Volume Forecast by Application
11.4.1. School laboratory
11.4.2. Biopharmaceutical Company
11.4.3. Synthesis Services Company
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Peptide Synthesizer Market Size and Volume Forecast by Type
11.7.1. Mcg-mg
11.7.2. Mg-g
11.7.3. G-kg
11.7.4. Abovekg
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Peptide Synthesizer Demand Share, 2019-2026
12. Asia Pacific Peptide Synthesizer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Peptide Synthesizer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Peptide Synthesizer Market Size and Volume Forecast by Application
12.4.1. School laboratory
12.4.2. Biopharmaceutical Company
12.4.3. Synthesis Services Company
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Peptide Synthesizer Market Size and Volume Forecast by Type
12.7.1. Mcg-mg
12.7.2. Mg-g
12.7.3. G-kg
12.7.4. Abovekg
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Peptide Synthesizer Demand Share, 2019-2026
13. Middle East & Africa Peptide Synthesizer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Peptide Synthesizer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Peptide Synthesizer Market Size and Volume Forecast by Application
13.4.1. School laboratory
13.4.2. Biopharmaceutical Company
13.4.3. Synthesis Services Company
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Peptide Synthesizer Market Size and Volume Forecast by Type
13.7.1. Mcg-mg
13.7.2. Mg-g
13.7.3. G-kg
13.7.4. Abovekg
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Peptide Synthesizer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Peptide Synthesizer Market: Market Share Analysis
14.2. Peptide Synthesizer Distributors and Customers
14.3. Peptide Synthesizer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AAPPTec
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. PTI
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. PSI
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CEM
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biotage
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shimadzu
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Activotec
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CS Bio
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Intavis AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hainan JBPharm
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
